Structural heart disease (SHD) refers to a wide category of percutaneous treatments for the patients with both acquired heart disease and congenital heart disease (CHD) that involves functional and structural abnormalities of cardiac chambers, proximal great vessels, and heart valves.
Drivers & Restraints
The global market is anticipated to rise at a considerable rate during the forecast period. In the recent years, the market was growing at a steady rate and with the rising adoption of strategies by key players; the market is expected to rise over the projected horizon. Rise in incidence of structural heart diseases, technological advancements, and increase in demand for minimally invasive techniques are factors that drive the structural heart devices market.
Sample Link Here: https://www.crystalmarketresearch.com/report-sample/HC0912771
Heart Repair Devices
Atrial Septal Defect (ASD)
Patent Foramen Ovale (PFO)
Ventricular Septal Defect (VSD)
Aortic Valve Stenosis
The market has been segment into North America, South America, Europe, Asia-Pacific, and Middle East and Africa. North America dominated by market share in 2016 and is followed by Europe.
Purchase Link Here: https://www.crystalmarketresearch.com/checkout/HC0912771
St. Jude Medical, Inc.
Medical Technology Est.
Boston Scientific Corporation
Micro Interventional Devices, Inc.
Edwards Lifesciences Corporation
JenaValve Technology, Inc.